Suppression of Evi1 promotes the osteogenic differentiation and inhibits the adipogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro

An,Qijun; Wu,Dou; Ma,Yuehong; Zhou,Biao; Liu,Qiang

doi:10.3892/ijmm.2015.2385

Suppression of Evi1 promotes the osteogenic differentiation and inhibits the adipogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro

Authors:
- Qijun An
- Dou Wu
- Yuehong Ma
- Biao Zhou
- Qiang Liu
View Affiliations

Affiliations: Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Department of Orthopaedics, Shanxi Dayi Hospital, Shanxi Academy of Medical Sciences, Taiyuan, Shanxi 030032, P.R. China, Shanxi Provincial People's Hospital, Taiyuan, Shanxi 030012, P.R. China
Published online on: October 21, 2015 https://doi.org/10.3892/ijmm.2015.2385
Pages: 1615-1622

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoporosis (OP) is considered a complex disease with a strong genetic impact, mainly affecting post-menopausal women and is also a common cause of fracture. Elucidating the molecular mechanisms that regulate the osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) is crucial to developing treatment strategies to combat OP. In the present study, we found that ectopic viral integration site‑1 (Evi1) was highly expressed during the process of adipogenesis of rat BMSCs. Notably, Evi1 levels markedly increased on day 3 of adipogenic differentiation following the addition of adipogenic induction supplements. In addition, we interfered with the expression of the Evi1 gene in the adipogenesis of BMSCs by supplementing adenoviral plasmids and measured the expression levels of bone sialoprotein (BSP), osteocalcin (OCN), osteopontin (OPN), peroxisome proliferator‑activated receptor γ2 (PPARγ2) and lipoprotein lipase (LPL) by RT-qPCR and western blot analysis. The mRNA and protein levels of osteogenic and adipogenic markers in the BMSCs were up‑ and downregulated, respectively following the silencing of siEvi1. Our experimental results substantiate that the suppression of Evi1 in BMSCs by RNA interference inhibits adipogenic differentiation, while it promotes osteogenic differentiation. The results from our study demonstrated that the Evi1 gene may be targeted as a therapeutic strategy for promoting bone formation.

View Figures

View References

1	Weinstein RS, Jilka RL, Parfitt AM and Manolagas SC: Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 102:274–282. 1998. View Article : Google Scholar : PubMed/NCBI
2	Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN and Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature. 367:284–287. 1994. View Article : Google Scholar : PubMed/NCBI
3	Seeman E: Bone quality: The material and structural basis of bone strength. J Bone Miner Metab. 26:1–8. 2008. View Article : Google Scholar
4	Pietschmann P, Rauner M, Sipos W and Kerschan-Schindl K: Osteoporosis: An age-related and gender-specific disease - a mini-review. Gerontology. 55:3–12. 2009. View Article : Google Scholar
5	Kassem M and Abdallah BM: Human bone-marrow-derived mesenchymal stem cells: Biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res. 331:157–163. 2008. View Article : Google Scholar
6	Egermann M, Heil P, Tami A, Ito K, Janicki P, Von Rechenberg B, Hofstetter W and Richards PJ: Influence of defective bone marrow osteogenesis on fracture repair in an experimental model of senile osteoporosis. J Orthop Res. 28:798–804. 2010.
7	Rodriguez JP, Astudillo P, Rios S and Pino AM: Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther. 3:208–218. 2008. View Article : Google Scholar : PubMed/NCBI
8	Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
9	Uejima S, Okada K, Kagami H, Taguchi A and Ueda M: Bone marrow stromal cell therapy improves femoral bone mineral density and mechanical strength in ovariectomized rats. Cytotherapy. 10:479–489. 2008. View Article : Google Scholar : PubMed/NCBI
10	Ocarino Nde M, Boeloni JN, Jorgetti V, Gomes DA, Goes AM and Serakides R: Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect Tissue Res. 51:426–433. 2010. View Article : Google Scholar : PubMed/NCBI
11	Lien CY, Chih-Yuan Ho K, Lee OK, Blunn GW and Su Y: Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res. 24:837–848. 2009. View Article : Google Scholar
12	Park S-H, Sim WY, Min B-H, Yang SS, Khademhosseini A and Kaplan DL: Chip-based comparison of the osteogenesis of human bone marrow- and adipose tissue-derived mesenchymal stem cells under mechanical stimulation. PLoS One. 7:e466892012. View Article : Google Scholar : PubMed/NCBI
13	Mimeault M and Batra SK: Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev. 4:27–49. 2008. View Article : Google Scholar : PubMed/NCBI
14	Rodríguez JP, Garat S, Gajardo H, Pino AM and Seitz G: Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem. 75:414–423. 1999. View Article : Google Scholar : PubMed/NCBI
15	Ishibashi J, Firtina Z, Rajakumari S, Wood KH, Conroe HM, Steger DJ and Seale P: An Evi1-C/EBPβ complex controls peroxisome proliferator-activated receptor γ2 gene expression to initiate white fat cell differentiation. Mol Cell Biol. 32:2289–2299. 2012. View Article : Google Scholar : PubMed/NCBI
16	Yue B, Lu B, Dai KR, Zhang XL, Yu CF, Lou JR and Tang TT: BMP2 gene therapy on the repair of bone defects of aged rats. Calcif Tissue Int. 77:395–403. 2005. View Article : Google Scholar : PubMed/NCBI
17	Fu L, Tang T, Miao Y, Zhang S, Qu Z and Dai K: Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone. 43:40–47. 2008. View Article : Google Scholar : PubMed/NCBI
18	Liang J, Liu C, Qiao A, Cui Y, Zhang H, Cui A, Zhang S, Yang Y, Xiao X, Chen Y, et al: MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis. J Hepatol. 58:535–542. 2013. View Article : Google Scholar
19	Rachner TD, Khosla S and Hofbauer LC: Osteoporosis: Now and the future. Lancet. 377:1276–1287. 2011. View Article : Google Scholar : PubMed/NCBI
20	Manolagas SC: Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 21:115–137. 2000.PubMed/NCBI
21	Khosla S: Minireview: The OPG/RANKL/RANK system. Endocrinology. 142:5050–5055. 2001. View Article : Google Scholar : PubMed/NCBI
22	Schwartzman J and Yazici Y: Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 354:2390–2391; author reply 2390–2391. 2006. View Article : Google Scholar : PubMed/NCBI
23	Watts NB, Roux C, Modlin JF, Brown JP, Daniels A, Jackson S, Smith S, Zack DJ, Zhou L, Grauer A, et al: Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: Coincidence or causal association? Osteoporos Int. 23:327–337. 2012. View Article : Google Scholar :
24	Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, Bredius R, Mancini G, Cant A, Bishop N, et al: Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. Nat Genet. 39:960–962. 2007. View Article : Google Scholar : PubMed/NCBI
25	James AW, Pang S, Askarinam A, Corselli M, Zara JN, Goyal R, Chang L, Pan A, Shen J, Yuan W, et al: Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev. 21:2170–2178. 2012. View Article : Google Scholar : PubMed/NCBI
26	Pei L and Tontonoz P: Fat's loss is bone's gain. J Clin Invest. 113:805–806. 2004. View Article : Google Scholar : PubMed/NCBI
27	Gimble JM and Nuttall ME: The relationship between adipose tissue and bone metabolism. Clin Biochem. 45:874–879. 2012. View Article : Google Scholar : PubMed/NCBI
28	Beresford JN, Bennett JH, Devlin C, Leboy PS and Owen ME: Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci. 102:341–351. 1992.PubMed/NCBI
29	Ho PA, Alonzo TA, Gerbing RB, Pollard JA, Hirsch B, Raimondi SC, Cooper T, Gamis AS and Meshinchi S: High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: A report from the children's oncology group. Br J Haematol. 162:670–677. 2013. View Article : Google Scholar : PubMed/NCBI